Related Experiment Video
Updated: Feb 11, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Neurodevelopmental outcome in 22q11.2 deletion syndrome and management
Ann Swillen1, Edward Moss2, Sasja Duijff3
1Department of Human Genetics, KU Leuven, Leuven, Belgium.
Insights
22q11.2 deletion syndrome (22q11.2 DS) increases risk for neurodevelopmental and behavioral issues. Early identification of risk and protective factors is crucial for timely intervention and improved outcomes in affected individuals.
Area of Science:
- Neuroscience
- Genetics
- Developmental Psychology
Background:
- 22q11.2 deletion syndrome (22q11.2 DS) is associated with significant neurodevelopmental challenges.
- Individuals with 22q11.2 DS often experience cognitive deficits, behavioral problems, and social-emotional difficulties.
Purpose of the Study:
- To review factors influencing neurodevelopmental outcomes in 22q11.2 DS.
- To discuss the cognitive phenotype and developmental trajectories in 22q11.2 DS.
- To highlight implications for clinical practice and management.
Main Methods:
- This is a review article, synthesizing existing research.
- Focuses on identifying early risk and protective factors.
- Examines cognitive and behavioral phenotypes across the lifespan.
Main Results:
- Common issues include intellectual disability, attention deficits, and social processing impairments.
- Early life factors can predict neurodevelopmental outcomes.
- Understanding developmental trajectories is key for intervention.
Conclusions:
- Early detection of risk and resilience factors in 22q11.2 DS is clinically vital.
- Tailored interventions based on individual trajectories can improve outcomes.
- Further research is needed to refine clinical management strategies.
Abstract:
The 22q11.2 deletion syndrome (22q11.2 DS) places affected individuals at an increased risk for neurodevelopmental/cognitive, behavioral and social-emotional difficulties. Poor cognitive functioning and intellectual disabilities, attention and executive functioning deficits, learning disorders, emotional dysregulation and impairments in social processing are common among individuals with 22q11.2 DS. Identifying risk and protective/resilience factors that can be detected in early life and can predict neurodevelopmental outcomes for people with 22q11.2 DS is of significant clinical relevance and might allow for early detection and intervention. Given the focus of this review, we will discuss the possible contributing factors that influence the neurodevelopmental outcome in 22q1.2 DS, the cognitive phenotype in 22q11.2 DS, the different developmental trajectories across life span, and the implications for clinical practice and management.
Related Concept Videos
Acute Coronary Syndrome V: Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Irritable Bowel Syndrome III: Medical and Nursing Management
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...

